Locations across Queensland within Queensland Cardiovascular Group

Phone (07) 3016 1111

Dr Kin Chee

MBBS | FRACP

Education and
Training

Fellow in Cardiac Electrophysiology
The Royal Jubilee Hospital | British Columbia, Canada

Fellow of the Royal Australasian College of Physicians (FRACP)
Royal Australasian College of Physicians | Australia

Fellow in Advanced Heart Failure and Transplant
The Prince Charles Hospital | Brisbane, Australia

Bachelor of Medicine, Bachelor of Surgery (MBBS)
Malaysia

Procedures and Conditions​

cardioversion treatment icon
Cardioversion
radiofrequency ablation
Radiofrequency Ablation
implantable cardioverter defibrillator
Defibrillators
pacemakers icon
Pacemakers
cardiac resynchronisation therapy
Cardiac Resynchronisation Devices

About Dr Chee

Dr Kin Chee is an Associate of the Queensland Cardiovascular Group, and a Fellow of the Royal Australasian College of Physicians.

He has sub-specialty training in cardiac electrophysiology and advanced heart failure, and specialises in heart rhythm disorders and cardiac electronic implanted devices.

Dr Chee originally came from Malaysia, and completed his basic and advanced cardiology training at The Canberra Hospital.

He did a year-long Fellowship in Advanced Heart Failure and Transplant at The Prince Charles Hospital in Brisbane. He then gained further experience including complex ablation over a two-year Fellowship at one of the largest ablation centres in North America, The Royal Jubilee Hospital in British Columbia, Canada.

Professional Memberships
and Awards

Royal Australasian College of Physicians (FRACP) Fellow

surgery

Research and Publications​

  1. (2013). The Evolving Trends of Atrial Fibrillation Ablation from 2007-2012. Poster Canadian Cardiovascular Congress, Montreal, Canada
  2. (2012). Atrial Fibrillation Type Is The Strongest Predictor for Repeat Ablation. Poster Canadian Cardiovascular Congress, Toronto, Canada
  3. (2012). Carto-Based Pulmonary Vein Impedance Assessment during Atrial fibrillation Ablation. Poster Canadian Cardiovascular Congress, Toronto, Canada
  4. (2011). Is P wave duration on 12 lead ECG useful to select stroke patient for Holter Monitoring? Poster 16th World Congress on Heart Disease Annual Scientific Sessions, Vancouver, Canada
  5. (2011). An Institutional Experience of Cardiac Transplantation for Congenital Heart Disease. Poster CSANZ
  6. (2011). Chemotherapy induced Cardiomyopathy. Poster CSANZ
  7. (2012). Audit on Outcome of Right Heart Study in Patient who were on warfarin at Prince Charles Hospital
  8. (2011). Audit on Outcomes of Femoral Coronary Intervention Access in the Canberra Hospita